Advocates request Cepheid immediately reduce the price of Xpert tests to US$ 5, inclusive of service and maintenance.

Médecins Sans Frontières releases the 6th edition of DR-TB Drugs Under the Microscope: 5 Urgent Actions to Improve DR-TB Treatment.

In the battle against antibiotic resistance, some scientists are trying a new approach: re-sensitising bacteria to drugs they no longer respond to so that existing antibiotics can hit their target once more.

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).

A study from Botswana published in the October issue of the Journal of Acquired Immune Deficiency Syndromes provides important scientific evidence, but not strong enough data for a policy change, on the use of a dolutegravir-based antiretroviral therapy (ART) regimen along with a rifampicin-based anti-tuberculosis (TB) regimen, for people living with HIV and TB coinfection.

NK News: North Korea could face major tuberculosis medication shortage, NGO warns

7 million people receive record levels of lifesaving TB treatment but 3 million still miss out. TB remains the top infectious killer in the world.

Meaningful engagement of communities affected by TB has been inadequate in development of National Strategic Plan (NSP). Despite communities of people affected by TB are critical to ending TB yet, they are most times excluded in major decision-making processes including planning and coordination of NSP development.

Tuberculosis is one of South Africa’s biggest health challenges with 322,000 new cases diagnosed each year, about 3.4% of which have some form of drug-resistance.